Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Edgardo S Santos
BIBF 1120/Nintedanib: A New Triple Angiokinase Inhibitor-Directed Therapy in Patients With Non-Small Cell Lung Cancer
Expert Opinion on Investigational Drugs
Medicine
Pharmacology
Immunotherapy: Is a Minor God Yet in the Pantheon of Treatments for Lung Cancer?
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Related publications
BIBF 1120 (Nintedanib), a Triple Angiokinase Inhibitor, Induces Hypoxia but Not EMT and Blocks Progression of Preclinical Models of Lung and Pancreatic Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker in Vivo
Clinical Cancer Research
Cancer Research
Oncology
New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Immune-Checkpoint Inhibitor Treatment of Non-Small Cell Lung Cancer Patients
Jurnal Respirasi
Recent Advances in Targeted Small-Molecule Inhibitor Therapy for Non-Small-Cell Lung Cancer-An Update
Journal of Clinical Pharmacy and Therapeutics
Pharmacology
Maintenance Therapy Improves Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Lung
Pulmonary
Respiratory Medicine
Ifosfamide in Patients With Recurrent Non Small Cell Lung Cancer
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
A Novel PI3K Inhibitor iMDK Suppresses Non-Small Cell Lung Cancer Cooperatively With a MEK Inhibitor
Experimental Cell Research
Cell Biology
Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
